HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab is effective in the treatment of patients with idiopathic inflammatory myopathy.

AuthorsF J Garcia-Hernandez, R Gonzalez-Leon, M J Castillo-Palma, J Sanchez-Roman
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2011 Mar-Apr Vol. 29 Issue 2 Pg. 363-4 ISSN: 0392-856X [Print] Italy
PMID21385551 (Publication Type: Clinical Trial, Comment, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
Topics
  • Adult
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Antirheumatic Agents (administration & dosage)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myositis (drug therapy)
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: